Skip Main Navigation
Page Content
This event has ended

Dorsey 4D Symposium

Dorsey & Whitney LLP

Wednesday, October 29, 2014 from 8:30 AM to 7:00 PM (PDT)

Dorsey 4D Symposium

Ticket Information

Ticket Type Sales End Price Fee Quantity
Individual Admission Ended $199.00 $0.00

Who's Going

Loading your connections...

Share Dorsey 4D Symposium

Event Details

The Dorsey 4D Symposium addresses four key areas of the Life Sciences Industry: Devices, Diagnostics, Drugs, and Digital Health. Dedicated panels will dig deep into critical issues, current dynamics, and future trends to provide practical take-aways directly applicable to your business.

The target audience includes both emerging and established life sciences companies, venture capitalists, and other industry-related executives. Confirmed panelists to date include executives from Medtronic, Mayo Clinic, UnitedHealth, Piper Jaffray, CardioDx, NeoTract, RMI Partners, Sightline Partners, SilverBow Development, Accelemed Management, Specialty Medtech, Corventis, Optum360, Prospect+Health and ExploraMed Development.

Conference Details:

October 29, 2014

REGISTRATION: 8:30 a.m. - 9:00 a.m.

CONFERENCE: 9:00 a.m. - 5:00 p.m.

HOSTED NETWORKING: 5:00 p.m. - 7:00 p.m.

Palo Alto Hills Golf & Country Club

* Continental breakfast and buffet lunch will be served.

Topics include:
  • New Global Frontiers - The recent recovery in life sciences activity was in large part driven by international elements. As evidenced by the Medtronic-Covidien deal, dealmakers are looking internationally to creatively structure transactions. Hear from seasoned executives about their international finanacing, business development and product commercialization efforts. Inversions? Repatriations? Designed in California and made in China? Understand the nuances of our new global environment.
  • A Look Into The Future: Corporate Trends for 2015 - While capital markets have recovered for therapeutics, M&A and partnering deals continue to dominate the deal landscape for life sciences. This moderated Q&A panel takes a look ahead and explores corporate trends in the industry for the upcoming year. Hear from buy-side and sell-side experts who have successfully executed groundbreaking transactions. They will share their recent experiences, explain what strategics are looking for and offer their prognosis for the future.
  • Incubating Innovation - Incubators continue to play a significant role in developing life sciences companies in the Bay Area and beyond. This roundtable brings together several leading incubators from the Bay Area to discuss their diverse approaches to organization, idea generation, financing, technology acquisition and development, and exit planning. Learn about their challenges, successes and visions for the future of the life science marketplace of ideas.
  • Taking it to Market: Winning Strategies to Commercialization - The best products and services will not reach the marketplace and achieve commerical success without significant planning for private payor or Medicare reimbursement. What are the dynamics in the reimbursement process in this era of evidenced-based medicine? How do you ensure not just coverage, but adequate coverage? How do you leverage coverage into commercial success? Hear from executives who have been through this process from start to finish and understand the challenges along the way.
  • Digital Health Innovations - With recent product launches by major technology companies affecting the digital health area, new opportunities are being created. This marks the beginning of a new era in the digital health segment of the life sciences industry. This session will focus on recent developments in the area and on where this segment of the industry will be going. Learn the ingredients to success in digital health.
  • Success in a Regulated Environment - The risks are real. In our heavily regulated industry, the potential for regulatory liability exists at every turn. Fines are in the hundreds of millions. How do you navigate the regulatory minefield? What are the current best practices for companies in the clinical phase or in the commercial phase? Hear from our panelists who have guided successful organizations through these serious issues.
  • Case Studies in Clinically-Driven Innovation - In this special talk, executives from Mayo Ventures discuss their experience in bringing innovation from clinical need in the Mayo Clinic to fruition. They will also address partnering opportunities with the clinic. They will also preview exciting and upcoming innovative developments from the clinic.

Business attire requested.

For more information, please visit:

Have questions about Dorsey 4D Symposium? Contact Dorsey & Whitney LLP

When & Where

Palo Alto Hills Golf and Country Club
3000 Alexis Dr
Palo Alto, CA 94304

Wednesday, October 29, 2014 from 8:30 AM to 7:00 PM (PDT)

  Add to my calendar


Dorsey & Whitney LLP

Located in the heart of Silicon Valley, Dorsey & Whitney’s Palo Alto office serves a wide variety of clients, from start-ups to established regional, national and international businesses. Dorsey’s Palo Alto attorneys provide exceptional service to their clients at all stages of their life cycle and work hard at collaborating and exceeding expectations in order to become their clients’ trusted advisors.

The Palo Alto office includes specialists in multiple practice areas, including life sciences and healthcare, corporate law, venture capital, mergers & acquisitions, tax, patent, business and commercial litigation, bankruptcy and restructuring, and labor & employment. The Palo Alto office also serves as a gateway to Dorsey’s specialists in over 60 practice areas throughout its worldwide platform in the U.S., Canada, Europe and Asia.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.